The oncogenic implications of metabolic dysfunction-associated steatotic liver disease. Journal of Renal and Hepatic Disorders, [S. l.], v. 10, n. 1, p. 14–23, 2026. DOI: 10.63268/jrenhp.v10i1.252. Disponível em: https://jrenhep.com/jrenhep/article/view/252. Acesso em: 19 jun. 2026.